Patient-Centric Strategy Drives Memo Therapeutics Forward

 
• By Anabel Costa-Ferreira
  
Memo Therapeutics prepares for Phase III trials (Shutterstock)
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Growth

More from In Vivo